LRMR Stock Analysis: Buy, Sell, or Hold?
LRMR - Larimar Therapeutics, Inc. Common Stock
$3.73
-0.56 (-12.97%)
▼
5d:
+13.22%
30d:
+8.28%
90d:
-23.2%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 13, 2026
29d
Get Alerted When LRMR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
3 traders called LRMR this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: LRMR shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: LRMR shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: LRMR is currently trading at $3.73, which is considered slightly high relative to its 30-day fair value range of $3.22 to $3.78.
Technical Outlook: Technically, LRMR is in a strong uptrend. Immediate support is located at $2.92, while resistance sits at $4.32. Short-term momentum is weak, with the stock down 13.0% recently.
Market Sentiment: LRMR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.40 (+286.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, LRMR is in a strong uptrend. Immediate support is located at $2.92, while resistance sits at $4.32. Short-term momentum is weak, with the stock down 13.0% recently.
Market Sentiment: LRMR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.40 (+286.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$3.22 -
$3.78
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
73.7%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-13.0%)
- BULLISH: Trading 286.6% below Wall St target ($14.40)
Trading Range Analysis
30-Day Trading Range
$3.22 -
$3.78
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$2.92
Resistance Level
$4.32
Current Trend
Strong Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.16
Wall Street Target
$14.40
(+286.6%)
Share & Embed Analysis
Last updated: July 14, 2026 6:15 AM ET
Data refreshes hourly during market hours. Next update: 7:15 AM
Data refreshes hourly during market hours. Next update: 7:15 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LRMR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
James E Flynn
BUY
5000000 shares
2026-02-27
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 45 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$277 | 51 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$124 | 61 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$99 | 44 HOLD |
